Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Gossamer Bio Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
GOSS
Nasdaq
8731
https://www.gossamerbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Gossamer Bio Inc
Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference
- May 14th, 2024 8:01 pm
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- May 10th, 2024 8:30 pm
Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
- May 7th, 2024 8:01 pm
Gossamer Bio and Chiesi partner for pulmonary hypertension treatment
- May 7th, 2024 9:11 am
Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
- May 6th, 2024 7:17 pm
UPDATE 1-Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
- May 6th, 2024 12:17 pm
Gossamer sells rights to drug it hopes can rival a new Merck therapy
- May 6th, 2024 12:11 pm
Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
- May 6th, 2024 11:30 am
Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
- May 3rd, 2024 12:02 pm
Gossamer Bio Decline Means Insider Profits Down To US$17k
- Apr 26th, 2024 10:51 am
13 Best Biotech Stocks To Buy Under $20
- Mar 13th, 2024 11:07 am
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
- Mar 12th, 2024 11:31 am
Should You Buy Gossamer Bio (GOSS) After Golden Cross?
- Mar 7th, 2024 2:55 pm
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
- Mar 5th, 2024 12:31 pm
12 Best Medical Stocks to Buy Under $10
- Feb 27th, 2024 8:30 am
7 Micro-Cap Stocks That Could Majorly Surprise Investors
- Jan 31st, 2024 7:23 pm
Gossamer Bio to Host Webcast to Discuss Latest Seralutinib Open-Label Extension Data on December 18, 2023
- Dec 13th, 2023 9:01 pm
Gossamer Bio Appoints Bob Smith as Chief Commercial Officer
- Dec 5th, 2023 12:01 pm
Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors
- Nov 29th, 2023 12:01 pm
COO & CFO of Gossamer Bio Picks Up 76% More Stock
- Nov 17th, 2023 10:51 am
Scroll